Kala Pharmaceuticals Inc
NASDAQ:KALA
| Market Cap (Intraday) | 398.07M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $8.31 |
| 50-Day MA | $7.92 |
| 200-Day MA | $9.00 |
Kala Pharmaceuticals, Inc. Stock, NASDAQ:KALA
490 Arsenal Way, Suite 120, Watertown, Massachusetts 02472
United States of America
Phone: +1.781.996.5252
Number of Employees: 136
Description
Kala Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Watertown, MA.